TrialCardiovascular diabetology2026

Metabolomic signatures of hepatic steatosis reveal heterogeneity in cardiometabolic risk and responses to lifestyle interventions in type 2 diabetes: a post hoc analysis.

Xianglin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.